Status:

COMPLETED

Pregnenolone Sulfate an Early Marker of the Memory Loss in Alzheimer's Disease

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Alzheimer Disease

Eligibility:

All Genders

70+ years

Brief Summary

The steroid pregnenolone sulfate (PREGS) may be one of the factors responsible for the memory decline related to normal aging or associated with Alzheimer's disease (AD). The purpose of this study is ...

Detailed Description

PREGS is a derivative of pregnenolone which the obligatory precursor of all steroid hormones originating from the gonads and adrenal glands. In rodents, PREGS has been demonstrated to improve memory p...

Eligibility Criteria

Inclusion

  • Subjects aged over 70 years who have signed informed consent for participation to the study and are affiliated to a social security regimen.
  • For patients: subjects with probable AD according to the DSM-IV criteria and the NINCDS/ADRDA criteria and with mild to moderate probable AD: MMSE score\> 15.
  • For Controls: subjects without cognitive deficits on neuropsychological tests: scores of MMSE \> 26 and of the 5 Word test equal to 10/10 and of the Clock Drawing test equal to 7/7.

Exclusion

  • Guardianship
  • History of cerebrovascular disease, Parkinson's disease, other known dementia, epilepsy
  • Major depression
  • Serious sensory disorders; deficits in language \& comprehension
  • Serious heart or hepatic insufficiencies, renal or respiratory failures
  • Unstable diabetes or endocrine disorders, thyroid dysfunction, cancer, inflammatory syndrome, malnutrition
  • Cognitive training during the 6 previous months
  • Medications: steroids (HRT, androgens, corticoids), anti-depressants, cholinesterase inhibitors, thyroid hormones, synthetic anti-thyroids
  • Contraindications for MRI: metallic implants \& claustrophobia

Key Trial Info

Start Date :

September 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2011

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT00912886

Start Date

September 1 2009

End Date

September 1 2011

Last Update

April 11 2013

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Assistance publique - Hôpitaux de Paris Hôpital Bicêtre

Le Kremlin-Bicêtre, France, 94275

2

Inserm Umr 788

Le Kremlin-Bicêtre, France, 94276

3

AP-HP Hôpital Rothschild

Paris, France, 75012

4

Assistance Publique - Hôpitaux de Paris Hôpital Broca

Paris, France, 75013